Advisor Net Financial, Inc Coherus Bio Sciences, Inc. Transaction History

Advisor Net Financial, Inc

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Jan 19, 2022	SELL	$15.81 - $18.99 $16,442 - $19,749	-1,040 Closed	0 $0
Q3 2021 Oct 15, 2021	SELL	$12.68 - $17.79 $5,262 - $7,382	-415 Reduced 28.52%	1,040 $17,000
Q2 2021 Jul 06, 2021	BUY	$12.95 - $15.41 $5,374 - $6,395	415 Added 39.9%	1,455 $20,000
Q4 2020 Feb 04, 2021	BUY	$16.56 - $18.94 $17,222 - $19,697	1,040 New	1,040 $18,000

132

76.9M

40.7K

50.1K

Ticker CHRS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 77,724,600
Market Cap $91.7M
Description
Coherus BioSciences, Inc., a biopharmaceutical company, focuses on the biosimilar and immuno-oncology market primarily in the United States. The company markets UDENYCA, a biosimilar to Neulasta, a long-acting granulocyte stimulating colony factor in the United States. Its pipeline products include biosimilars of Humira, Avastin, and Lucentis. T...

Get notified when there are updates to the investment portfolio of Advisor Net Financial, Inc, based on Form 13F filings with the SEC.

Stay updated on Advisor Net Financial, Inc with notifications on news.